These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22120047)

  • 1. The rugged landscape of drug design.
    Nat Genet; 2011 Nov; 43(12):1165. PubMed ID: 22120047
    [No Abstract]   [Full Text] [Related]  

  • 2. Spain. New cancer center makes a big splash.
    Bosch X
    Science; 2002 Mar; 295(5562):1995. PubMed ID: 11896248
    [No Abstract]   [Full Text] [Related]  

  • 3. France lays plans for premier cancer centre in Toulouse.
    Abbott A
    Nature; 2005 Mar; 434(7029):5. PubMed ID: 15744258
    [No Abstract]   [Full Text] [Related]  

  • 4. A place in the sun.
    Abbott A
    Nature; 2007 Mar; 446(7132):124-5. PubMed ID: 17344823
    [No Abstract]   [Full Text] [Related]  

  • 5. Florida welcomes Scripps as critics predict big-money flop.
    Dalton R
    Nature; 2003 Nov; 426(6962):4. PubMed ID: 14603275
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of Russian science.
    Georgiev G; Sverdlov E
    Science; 2010 Oct; 330(6000):11. PubMed ID: 20929777
    [No Abstract]   [Full Text] [Related]  

  • 7. Singapore. Novartis kicks off institute for neglected diseases.
    Normile D
    Science; 2003 Feb; 299(5608):811. PubMed ID: 12574598
    [No Abstract]   [Full Text] [Related]  

  • 8. Semiprivate research: best of both worlds.
    Nature; 1992 Oct; 359(6396):577. PubMed ID: 1406989
    [No Abstract]   [Full Text] [Related]  

  • 9. Biologistes sans frontières.
    Nat Cell Biol; 2007 Jun; 9(6):613. PubMed ID: 17541410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World's academies seek a sustainable future.
    Triendl R
    Nature; 2000 Jun; 405(6786):501. PubMed ID: 10850685
    [No Abstract]   [Full Text] [Related]  

  • 11. Epilogue: New drugs for neglected diseases.
    Pogge T; Hollis A
    Camb Q Healthc Ethics; 2011 Apr; 20(2):329-34. PubMed ID: 21435308
    [No Abstract]   [Full Text] [Related]  

  • 12. France to focus on a few biotech clusters.
    Balcon E
    Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
    [No Abstract]   [Full Text] [Related]  

  • 13. Why French politics and science don't mix.
    Nat Mater; 2004 May; 3(5):275. PubMed ID: 15122212
    [No Abstract]   [Full Text] [Related]  

  • 14. Neglected diseases get vaccine research boost.
    Abbott A
    Nature; 2008 Feb; 451(7182):1037. PubMed ID: 18305506
    [No Abstract]   [Full Text] [Related]  

  • 15. Global update: Canada.
    Willemse L; Isasi R; Lyall D
    Regen Med; 2011 Nov; 6(6 Suppl):140-3. PubMed ID: 21999277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scripps to get less from Sandoz.
    Anderson C
    Science; 1994 May; 264(5162):1077. PubMed ID: 8178164
    [No Abstract]   [Full Text] [Related]  

  • 17. Research centers. Science with an agenda: NSF expands centers program.
    Mervis J
    Science; 2002 Jul; 297(5581):506-9. PubMed ID: 12142512
    [No Abstract]   [Full Text] [Related]  

  • 18. San Diego.
    Howard K
    Nature; 2003 Dec; 426(6967):689. PubMed ID: 14668871
    [No Abstract]   [Full Text] [Related]  

  • 19. Canadian Institutes of Health Research budgetary dilemma: unprecedented growth and program reductions.
    Bernstein A
    CMAJ; 2003 Sep; 169(6):567-8. PubMed ID: 12975223
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug discovery for the developing world: progress at the Novartis Institute for Tropical Diseases.
    Jones CL; Yeung BK; Manjunatha U; Shi PY; Bodenreider C; Diagana TT
    Nat Rev Drug Discov; 2015 Jun; 14(6):442-4. PubMed ID: 26027536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.